MetLife Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $107M | Sell |
493,002
-16,177
| -3% | -$3.59M | 0.55% | 22 |
|
|
2025
Q4 | $116M | Sell |
509,179
-13,109
| -3% | -$2.99M | 0.56% | 20 |
|
|
2025
Q3 | $121M | Sell |
522,288
-8,532
| -2% | -$1.74M | 0.58% | 20 |
|
|
2025
Q2 | $98.5M | Buy |
530,820
+38,847
| +8% | +$7.22M | 0.58% | 21 |
|
|
2025
Q1 | $103M | Sell |
491,973
-9,593
| -2% | -$1.86M | 0.56% | 25 |
|
|
2024
Q4 | $89.1M | Buy |
501,566
+7,305
| +1% | +$1.34M | 0.48% | 26 |
|
|
2024
Q3 | $97.6M | Sell |
494,261
-12,370
| -2% | -$2.31M | 0.56% | 22 |
|
|
2024
Q2 | $86.9M | Buy |
506,631
+20,261
| +4% | +$3.36M | 0.52% | 25 |
|
|
2024
Q1 | $88.6M | Sell |
486,370
-14,951
| -3% | -$2.58M | 0.6% | 23 |
|
|
2023
Q4 | $77.7M | Sell |
501,321
-8,801
| -2% | -$1.28M | 0.56% | 22 |
|
|
2023
Q3 | $76M | Sell |
510,122
-11,242
| -2% | -$1.65M | 0.59% | 22 |
|
|
2023
Q2 | $70.2M | Sell |
521,364
-5,594
| -1% | -$820K | 0.51% | 25 |
|
|
2023
Q1 | $84M | Sell |
526,958
-5,298
| -1% | -$810K | 0.6% | 21 |
|
|
2022
Q4 | $86M | Sell |
532,256
-10,453
| -2% | -$1.6M | 0.65% | 20 |
|
|
2022
Q3 | $72.8M | Sell |
542,709
-5,797
| -1% | -$832K | 0.61% | 22 |
|
|
2022
Q2 | $84M | Sell |
548,506
-11,627
| -2% | -$1.78M | 0.65% | 20 |
|
|
2022
Q1 | $90.8M | Buy |
560,133
+169,534
| +43% | +$24.6M | 0.59% | 21 |
|
|
2021
Q4 | $52.9M | Sell |
390,599
-8,536
| -2% | -$1.01M | 0.43% | 35 |
|
|
2021
Q3 | $43.1M | Sell |
399,135
-10,355
| -3% | -$1.18M | 0.39% | 45 |
|
|
2021
Q2 | $46.1M | Sell |
409,490
-11,319
| -3% | -$1.27M | 0.4% | 37 |
|
|
2021
Q1 | $45.5M | Sell |
420,809
-7,945
| -2% | -$850K | 0.42% | 36 |
|
|
2020
Q4 | $45.9M | Sell |
428,754
-18,708
| -4% | -$1.8M | 0.43% | 35 |
|
|
2020
Q3 | $39.2M | Sell |
447,462
-13,456
| -3% | -$1.27M | 0.43% | 39 |
|
|
2020
Q2 | $45.3M | Buy |
460,918
+79,733
| +21% | +$7.02M | 0.51% | 30 |
|
|
2020
Q1 | $29M | Sell |
381,185
-11,663
| -3% | -$993K | 0.4% | 47 |
|
|
2019
Q4 | $34.8M | Sell |
392,848
-9,501
| -2% | -$789K | 0.36% | 47 |
|
|
2019
Q3 | $30.5M | Sell |
402,349
-5,137
| -1% | -$352K | 0.34% | 56 |
|
|
2019
Q2 | $29.6M | Sell |
407,486
-11,880
| -3% | -$934K | 0.32% | 57 |
|
|
2019
Q1 | $33.8M | Sell |
419,366
-10,828
| -3% | -$886K | 0.37% | 50 |
|
|
2018
Q4 | $39.7M | Sell |
430,194
-10,319
| -2% | -$907K | 0.48% | 32 |
|
|
2018
Q3 | $41.7M | Sell |
440,513
-5,609
| -1% | -$532K | 0.43% | 37 |
|
|
2018
Q2 | $41.3M | Sell |
446,122
-33,604
| -7% | -$3.28M | 0.49% | 33 |
|
|
2018
Q1 | $45.4M | Sell |
479,726
-13,500
| -3% | -$1.48M | 0.53% | 30 |
|
|
2017
Q4 | $47.7M | Buy |
+493,226
| New | +$46.5M | 0.54% | 30 |
|
Other funds holding ABBV
VCM
VPM
MetLife Investment Management's ABBV Position: Q1 2026 in Review
MetLife Investment Management reduced its AbbVie (ABBV) stake by 3.2% in Q1 2026, selling an estimated $3.59M and leaving 493,002 shares worth $107M. The position accounts for 0.55% of the portfolio, ranked #22.
MetLife Investment Management first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $121M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- MetLife Investment Management held 493,002 shares of AbbVie worth $107M as of Q1 2026.
- MetLife Investment Management sold 16,177 AbbVie shares in Q1 2026, an estimated $3.59M.
- AbbVie made up 0.55% of MetLife Investment Management's portfolio in Q1 2026, its #22 holding.
- MetLife Investment Management first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's AbbVie position peaked at $121M in Q3 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.